Covid-19 aşılarının karşılaştırılması

Covid-19 aşılarının karşılaştırılması
Bugüne kadar yaygın kullanım onayı almış ya da onay için başvurmuş olan aşıların bazı temel özellikleri aşağıda verilmiştir.

Prof. Dr. Hakan YAMAN



Kaynak:

1. WebMD. Four COVID Vaccines Compared. Medscape. Erişim: https://www.medscape.com/viewarticle/945401 . Erişim tarihi: 08.02.202

2. Remaly J. Experts: Pregnant Women Can Get COVID-19 Vaccine. Medscape. Erişim: https://www.webmd.com/vaccines/covid-19-vaccine/news/20201218/experts-pregnant-women-can-get-covid-vaccine#1. Erişim tarihi: 08.02021.

3. Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang H, Wang W, Zhang W, Li N, Xie Z, Ding L, You W, Zhao Y, Yang X, Liu Y, Wang Q, Huang L, Yang Y, Xu G, Luo B, Wang W, Liu P, Guo W, Yang X. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 Jan;21(1):39-51. doi: 10.1016/S1473-3099(20)30831-8. Epub 2020 Oct 15. PMID: 33069281; PMCID: PMC7561304.

4. Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 Feb;21(2):181-192. doi: 10.1016/S1473-3099(20)30843- Epub 2020 Nov 17. PMID: 33217362; PMCID: PMC7832443.

5. Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Egorova DA, Shmarov MM, Nikitenko NA, Gushchin VA, Smolyarchuk EA, Zyryanov SK, Borisevich SV, Naroditsky BS, Gintsburg AL; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 2:S0140-6736(21)00234-8. doi: 10.1016/S0140-6736(21)00234-8. Epub ahead of print. PMID: 33545094; PMCID: PMC7852454.

6. Lenharo M. Why COVID Vaccines Are Likely Safe for Pregnant People. scientificamerican. Erişim: scientificamerican.com/article/why-covid-vaccines-are-likely-safe-for-pregnant-people1. Erişim tarihi: 08.02.2021.

Öne Çıkanlar